Top 10 R&D spenders over the decade - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Top 10 R&D spenders over the decade

Apr 17, 2003

Research and Development (R&D) expense is a vital ingredient for the growth of a company, as new products and innovations are the life-blood for sustaining the growth in any industry. Let us evaluate India Inc.’s scorecard on this count. Although India’s share is very miniscule, research and development has come a long way. More and more companies are making a conscious effort towards R&D. Some of the relative new entrants in the field of R&D include Telco, ONGC and IOC. All three have started to spend on R&D post FY95. So on an 8-year CAGR basis, IOC and ONGC’s R&D spending has increased by over 16% each, while Telco’s spending has increased at a mere 3%. But if one compares the R&D expense with sales then the ratio is not too enthusing.

Top 10 R&D spenders
Top R&D spenders FY02
(Rs m) R&D exp. % of Sales
Dr. Reddy'S Laboratories Ltd. 980 6.0%
Tata Engineering & Locomotive Co. Ltd. 924 1.3%
Reliance Industries Ltd. 901 0.2%
Bharat Electronics Ltd. 896 4.7%
Bharat Heavy Electricals Ltd. 871 1.3%
Oil & Natural Gas Corpn. Ltd. 803 0.4%
Ranbaxy Laboratories Ltd. 771 3.4%
Mahindra & Mahindra Ltd. 690 2.1%
Indian Oil Corpn. Ltd. 686 0.1%
I T I Ltd. 581 2.6%

The top spenders in R&D continue to be pharma companies. Dr. Reddy’s has been the top spender in FY02 (Rs 980 m) with a 53% CAGR over the last decade (6% of sales). In the top 50 R&D investors there are 13 pharma companies, 10 companies from the auto industry and 5 from the software industry. This clearly indicates that pharma companies continue to rule the roost on the Indian R&D front.

Among auto companies, Telco is the top R&D investor (Rs 924 m), R&D as 1.3% of sales. Two-wheeler companies have also upped R&D spends significantly over the last few years. Bajaj Auto’s spends have clocked a 37% CAGR on R&D. For that matter, even TVS Motors has been spending at 39% CAGR. This indicates that the companies are spending more in order to roll out new models on a regular basis, which would help them in saving their turf and keep them ahead in the race for market dominance.

Company Name Sales CAGR* R&D exp. CAGR*
Dr. Reddy'S Laboratories Ltd. 28.9% 52.8%
Tata Engineering & Locomotive Co. Ltd. 10.0% 3.4%**
Reliance Industries Ltd. 33.8% 22.5%
Bharat Electronics Ltd. 9.7% 15.3%
Bharat Heavy Electricals Ltd. 7.7% 7.0%
Oil & Natural Gas Corpn. Ltd. 14.8% 19.4%**
Ranbaxy Laboratories Ltd. 17.8% 19.3%**
Mahindra & Mahindra Ltd. 11.4% 40.0%
Indian Oil Corpn. Ltd. 16.6% 18.2%**
I T I Ltd. 6.8% 25.4%
* CAGR FY92-FY02   ** CAGR FY95-FY02

In FY02, Hero Honda was the market leader with 51% share and Bajaj Auto had a 23% market share in the motorcycle segment. But in FY02, Bajaj Auto’s R&D spending has been 1% of sales, as compared to 0.2% of sales for Hero Honda. Bajaj Auto probably has been forced to spend more to keep its dominance in the two-wheeler segment intact. Also, Hero Honda till date has had Honda’s support on the technical side. But the higher spending by Bajaj Auto has reflected in market share tally in FY03. During the fiscal, Hero Honda gave away market share and finished with 44% of the motorcycle pie, whereas Bajaj Auto gained share (albeit marginally) to 25%. Of course, there are a lot of other reasons for a company’s success, but R&D is the stepping-stone for keeping ahead in the race.

Tough R&D spending as a percentage of sales maybe high (5%-6%) for pharma companies, when compared globally, in absolute terms it is very small. Glaxo spends around US$ 27 bn on R&D as compared to Dr. Reddy’s humble Rs 980 m. But atleast companies have realized the importance of investing in R&D. With globalization in full swing, domestic companies have to compete aggressively by way of innovative products and services. This can either come from internal spending and investment, or if the companies are not capable, they can bring in strategic partners to help them bridge this technological gap.

Equitymaster requests your view! Post a comment on "Top 10 R&D spenders over the decade". Click here!


More Views on News

The BSE AUTO Index Down 2% ; ASHOK LEYLAND Among Top Losers (Market Updates)

Sep 24, 2020 | Updated on Sep 24, 2020

The BSE AUTO Index Down at 17,213 (down 2.1%). Among the top losers in the BSE AUTO Index today are ASHOK LEYLAND, TATA MOTORS and MOTHERSON SUMI. Meanwhile, the BSE Sensex has plunged 1.4% to 37,304.

More Views on News

Most Popular

How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

Sep 11, 2020

This is how you can apply the greed and fear cycle in the market to pick stocks.

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

This Could Be the Best September for Auto Stocks (Profit Hunter)

Sep 11, 2020

Here's why I think this month could be a great for auto stocks.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...


Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms


Sep 24, 2020 01:55 PM